Leon Beyer

St. Josef Hospital
Bochum, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

An Immuno-Infrared Sensor Detects Preclinical Alzheimer's and Parkinson's Disease by Protein Misfolding.

An Immuno-Infrared Sensor Detects Preclinical Alzheimer's and Parkinson's Disease by Protein Misfolding.

Journal: The journal of physical chemistry. B

Published: April 24, 2026

Predictive value of plasma p-tau217 for Alzheimer's dementia compared to other blood-based biomarkers.

Predictive value of plasma p-tau217 for Alzheimer's dementia compared to other blood-based biomarkers.

Journal: EMBO molecular medicine

Published: January 21, 2026

From inflammation to neurodegeneration: an exploratory pilot study of a diagnostic framework for progression in MS.

From inflammation to neurodegeneration: an exploratory pilot study of a diagnostic framework for progression in MS.

Journal: Frontiers in neurology

Published: December 15, 2025

Serum Neurofilament Light Chain as a Biomarker for CIDP Diagnosis, Severity, and Treatment Outcome.

Serum Neurofilament Light Chain as a Biomarker for CIDP Diagnosis, Severity, and Treatment Outcome.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 05, 2025

Eomesodermin-expressing CD4 Th cells and association with multiple sclerosis progression and brain atrophy.

Eomesodermin-expressing CD4 Th cells and association with multiple sclerosis progression and brain atrophy.

Journal: Brain communications

Published: April 23, 2025

Association of Nonmodifiable Risk Factors With Alzheimer Disease Blood Biomarkers in Community-Dwelling Adults in the ESTHER Study.

Association of Nonmodifiable Risk Factors With Alzheimer Disease Blood Biomarkers in Community-Dwelling Adults in the ESTHER Study.

Journal: Neurology

Published: April 16, 2025

Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platform.

Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platform.

Journal: EMBO molecular medicine

Published: October 28, 2024

Mitochondrial DNA abundance in blood is associated with Alzheimer's disease- and dementia-risk.

Mitochondrial DNA abundance in blood is associated with Alzheimer's disease- and dementia-risk.

Journal: Molecular psychiatry

Published: October 27, 2023

Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study.

Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study.

Journal: Alzheimer's research & therapy

Published: July 13, 2023

Serum neurofilament light chain does not detect self-reported treatment-related fluctuations in chronic inflammatory demyelinating polyneuropathy.

Serum neurofilament light chain does not detect self-reported treatment-related fluctuations in chronic inflammatory demyelinating polyneuropathy.

Journal: European journal of neurology

Published: April 10, 2023

Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years.

Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years.

Journal: Alzheimer's research & therapy

Published: February 10, 2023

Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers.

Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers.

Journal: JAMA network open

Published: January 24, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026